Halozyme Therapeutics, Inc. (BMV:HALO)
Mexico · Delayed Price · Currency is MXN 1,395.66
+14.66 (1.06%)
At close: Feb 6, 2026
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of 162.64 billion as of February 10, 2026. Its market cap has increased by 13.37% in one year.
Market Cap
162.64B
Enterprise Value
177.02B
Revenue
22.80B
Ranking
n/a
PE Ratio
14.89
Stock Price
1,395.66
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 1.94B to 162.64B, an increase of 8,270.24%. That is a compound annual growth rate of 22.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 162.64B | 14.15% |
| Dec 31, 2025 | 142.48B | 12.41% |
| Dec 31, 2024 | 126.75B | 53.56% |
| Dec 29, 2023 | 82.54B | -45.00% |
| Dec 30, 2022 | 150.07B | 29.37% |
| Dec 31, 2021 | 116.00B | 1.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arca Continental | 347.52B |
| FIBRA Prologis | 137.97B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 124.41B |
| Fibra UNO | 109.98B |
| Grupo Elektra | 91.63B |
| Gentera | 82.71B |
| Corporación Moctezuma | 70.57B |
| Becle | 70.39B |